0000000000072866

AUTHOR

Laia Navarro

showing 3 related works from this author

Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: Role of an aggressive approach

2012

A sustained virological response (SVR) is achieved by 30% of naive liver transplantation (LT) recipients treated with pegylated interferon (PEG-IFN) and ribavirin (RBV). Almost no data are available about retreatment. The aim of this study was to assess the efficacy, tolerability, and SVR predictors of retreatment. Data were collected from 4 centers on the retreatment of prior nonresponders to standard therapy or PEG-IFN (with or without RBV) and relapsers. Seventy-nine of 301 treatment-experienced LT patients (26%), who had a median age of 59 years (range = 35-77 years) and were mostly male (72%) and infected with genotype 1 (87%), were retreated with PEG-IFN and RBV at a median of 6.9 yea…

Transplantationmedicine.medical_specialtyCirrhosisHepatologybusiness.industryRibavirinmedicine.medical_treatmentHepatitis C virusLiver transplantationmedicine.diseasemedicine.disease_causeGastroenterologyTacrolimusSurgerychemistry.chemical_compoundchemistryTolerabilityErythropoietinPegylated interferonInternal medicinemedicineSurgerybusinessmedicine.drugLiver Transplantation
researchProduct

Anemia is not predictive of sustained virological response in liver transplant recipients with hepatitis C virus who are treated with pegylated inter…

2011

In the immunocompetent setting, antiviral therapy–related anemia has recently been shown to be associated with a sustained virological response (SVR). Our goal was to assess whether this is also true for liver transplantation (LT). We included 160 LT patients with recurrent hepatitis C virus (HCV) who were treated with pegylated interferon and ribavirin (RBV) between 2002 and 2010; 76% of the patients were men, the median age of the patients was 56 years (range = 33-75 years), 63% had advanced fibrosis, and 86% were infected with HCV genotype 1a or 1b. The baseline immunosuppression was tacrolimus in 56% of the patients. Mycophenolate mofetil (MMF) was used in 15%. Anemia was defined as a h…

Transplantationmedicine.medical_specialtyHepatologybusiness.industryAnemiamedicine.medical_treatmentRibavirinHepatitis C virusRenal functionImmunosuppressionLiver transplantationmedicine.disease_causemedicine.diseaseGastroenterologychemistry.chemical_compoundchemistryErythropoietinPegylated interferonInternal medicineImmunologymedicineSurgerybusinessmedicine.drugLiver Transplantation
researchProduct

Oxidative and Nitrosative Pattern in Circulating Leukocytes of Very Early/Early Hepatocellular Carcinoma Patients

2020

Background/aim In chronic liver disease, various immune cell subsets exert pro or anti-tumour effects by releasing reactive oxygen and nitrogen species (ROS, RNS). Here, we evaluated the oxidative and nitrosative pattern in peripheral blood leukocyte subpopulations of early hepatocellular carcinoma (HCC) patients compared with HCC-free cirrhotic patients. Materials and methods Venous blood samples from 18 HCC-free cirrhotic patients and 17 early stage HCC patients were collected to determine ROS, RNS and reduced glutathione levels in isolated leukocytes analyzed by flow cytometry. Results Intracellular levels of ROS and glutathione were higher in lymphocytes, monocytes, and neutrophils from…

MaleCancer ResearchCarcinoma HepatocellularCirrhosisChronic liver diseasemedicine.disease_causeNitric oxide03 medical and health scienceschemistry.chemical_compound0302 clinical medicineImmune systemRisk FactorsSuperoxidesLeukocytesmedicineHumansEarly Hepatocellular CarcinomaAgedNeoplasm StagingAged 80 and overbusiness.industryLiver NeoplasmsGeneral MedicineGlutathioneMiddle AgedFlow CytometryNeoplastic Cells Circulatingmedicine.diseaseReactive Nitrogen Speciesdigestive system diseasesOxidative StressOncologychemistry030220 oncology & carcinogenesisImmunologyFemaleReactive Oxygen SpeciesbusinessOxidation-ReductionOxidative stressIntracellularAnticancer Research
researchProduct